BIONEXUS KC: Form 990, tax year 2017

View the entire original 990 at ProPublica ↗

Organization
BIONEXUS KC (EIN 43-1889037)
Tax period
2017-01-01 to 2017-12-31
Filed
2018-05-10
IRS object ID
201811309349303866
Schema version
2017v2.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2018-05-10T16:38:40-05:00ReturnTs
Tax Period End2017-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN341874260PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CBIZ MHM LLCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1700 WEST 47TH STREET SUITE 1100AddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64112ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2017-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN431889037EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1KANSAS CITY AREA LIFE SCIENCESBusinessNameLine1Txt
Business Name Line2INSTITUTE INCBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlKANSBusinessNameControlTxt
Phone8167537700PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line130 W PERSHING ROAD NO 210AddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64108ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonWAYNE O CARTERPersonNm
Person TitlePRESIDENTPersonTitleTxt
Phone8167537700PhoneNum
Signature2018-05-09SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonLISA BURKEPreparerPersonNm
PTINP00220718PTIN
Phone8169455500PhoneNum
FieldValueIRS element (for citing)
Tax2017TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerWAYNE O CARTERPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line130 W PERSHING ROAD NO 210AddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64108ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$1,703,232GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.KCLIFESCIENCES.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2000FormationYr
Legal Domicile StateMOLegalDomicileStateCd
Activity Or MissionTHE PURPOSE OF THIS ORGANIZATION IS TO PROMOTE AND FOSTER DEVELOPMENT OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA AND TO PROVIDE A PLATFORM FOR DEVELOPMENT AND COOPERATION IN THE AREA OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA.ActivityOrMissionDesc
Voting Members Governing Body11VotingMembersGoverningBodyCnt
Voting Members Independent10VotingMembersIndependentCnt
Total Employee6TotalEmployeeCnt
Total Volunteers36TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$1,724,324PYContributionsGrantsAmt
CY Contributions Grants$1,603,349CYContributionsGrantsAmt
PY Program Service Revenue$104,363PYProgramServiceRevenueAmt
CY Program Service Revenue$90,800CYProgramServiceRevenueAmt
PY Investment Income$900PYInvestmentIncomeAmt
CY Investment Income$9,083CYInvestmentIncomeAmt
PY Other Revenue$0PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$1,829,587PYTotalRevenueAmt
CY Total Revenue$1,703,232CYTotalRevenueAmt
PY Grants And Similar Paid$349,863PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$616,772CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$677,307PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$697,292CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$56,372CYTotalFundraisingExpenseAmt
PY Other Expenses$343,347PYOtherExpensesAmt
CY Other Expenses$400,834CYOtherExpensesAmt
PY Total Expenses$1,370,517PYTotalExpensesAmt
CY Total Expenses$1,714,898CYTotalExpensesAmt
PY Revenues Less Expenses$459,070PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$11,666CYRevenuesLessExpensesAmt
Total Assets BOY$2,014,840TotalAssetsBOYAmt
Total Assets EOY$2,003,174TotalAssetsEOYAmt
Total Liabilities BOY$0TotalLiabilitiesBOYAmt
Total Liabilities EOY$0TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$2,014,840NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$2,003,174NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE PURPOSE OF THIS ORGANIZATION IS TO PROMOTE AND FOSTER DEVELOPMENT OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA AND TO PROVIDE A PLATFORM FOR DEVELOPMENT AND COOPERATION IN THE AREA OF LIFE SCIENCES IN THE KANSAS CITY METROPOLITAN AREA.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$1,435,206ExpenseAmt
Grant$616,772GrantAmt
Revenue$90,800RevenueAmt
DescSEE SCHEDULE ODesc
Total Program Service Expenses$1,435,206TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying ActivitiesYes (1)LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Temp Or Permanent Endowments0TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With Officer Ent0BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl EntYes (1)RelatedOrganizationCtrlEntInd
Transaction With Control Ent0TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document8IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee6EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo ContributionsYes (1)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (1)QuidProQuoContriDisclInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
DAF Excess Business Holdings0DAFExcessBusinessHoldingsInd
Taxable Distributions0TaxableDistributionsInd
Distribution To Donor0DistributionToDonorInd
Indoor Tanning Services0IndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members11GoverningBodyVotingMembersCnt
Independent Voting Member10IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Other WebsiteYes (X)OtherWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1SHARON NEWMANBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone8167537700PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line130 W PERSHING ROAD STE 210AddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64108ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (12 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
WILLIAM S BERKLEY
DIRECTOR (CHAIR)0.50Yes (X)Yes (X)$0$0$0
DONALD CRAIG BRATER
DIRECTOR0.10Yes (X)$0$0$0
WAYNE O CARTER
PRESIDENT40.00Yes (X)Yes (X)$256,994$0$36,421
DAVID FRANTZE
DIRECTOR0.20Yes (X)$0$0$0
IRVINE O HOCKADAY JR
DIRECTOR0.30Yes (X)$0$0$0
ROBERT A KIPP
DIRECTOR (VICE CHAIRMAN)0.00Yes (X)Yes (X)$0$0$0
STEPHEN REINTJES
DIRECTOR (SECRETARY AND TREASURER)0.25Yes (X)Yes (X)$0$0$0
THOMAS SACK PHD
DIRECTOR0.30Yes (X)$0$0$0
ANNE D ST PETER
DIRECTOR0.30Yes (X)$0$0$0
STEVEN ST PETER MD
DIRECTOR0.30Yes (X)$0$0$0
DEBORAH WILKERSON
DIRECTOR0.30Yes (X)$0$0$0
KEITH A GARY
VICE PRESIDENT40.00Yes (X)$160,160$0$25,935
FieldValueIRS element (for citing)
Total Reportable Comp From Org$417,154TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$62,356TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K2IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
All Other Contributions$1,603,349AllOtherContributionsAmt
Total Contributions$1,603,349TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
LIFE SCIENCES DINNER900099$49,100$49,100
ONE HEALTH SYMPOSIUM900099$24,290$24,290
BIOINFORMATICS CONFERE900099$17,410$17,410
FieldValueIRS element (for citing)
Total Program Service Revenue$90,800TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$9,083TotalRevenueColumnAmt
Exclusion$9,083ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,703,232TotalRevenueColumnAmt
Related Or Exempt Func Income$90,800RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$9,083ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$616,772TotalAmt
Program Services$616,772ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$479,511TotalAmt
Program Services$341,043ProgramServicesAmt
Management And General$104,508ManagementAndGeneralAmt
Fundraising$33,960FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$150,046TotalAmt
Program Services$129,651ProgramServicesAmt
Management And General$7,454ManagementAndGeneralAmt
Fundraising$12,941FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$36,052TotalAmt
Program Services$2,503ProgramServicesAmt
Management And General$33,549ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$31,683TotalAmt
Program Services$22,740ProgramServicesAmt
Management And General$6,462ManagementAndGeneralAmt
Fundraising$2,481FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$29,645TotalAmt
Program Services$11,445ProgramServicesAmt
Management And General$18,200ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$37,104TotalAmt
Program Services$36,073ProgramServicesAmt
Management And General$1,029ManagementAndGeneralAmt
Fundraising$2FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$13,317TotalAmt
Program Services$5,799ProgramServicesAmt
Management And General$6,097ManagementAndGeneralAmt
Fundraising$1,421FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$22,363TotalAmt
Program Services$10,653ProgramServicesAmt
Management And General$11,704ManagementAndGeneralAmt
Fundraising$6FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$42,885TotalAmt
Program Services$25,731ProgramServicesAmt
Management And General$12,777ManagementAndGeneralAmt
Fundraising$4,377FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$16,982TotalAmt
Program Services$16,982ProgramServicesAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$8,188TotalAmt
Program Services$7,984ProgramServicesAmt
Management And General$204ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$5,203TotalAmt
Management And General$5,203ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
ANNUAL MTG & LIFE SCI.$96,141$96,141$0$0
CONSULTANTS$58,536$57,208$1,328$0
BIOINFORMATICS EVENT$16,208$16,208$0$0
MEMBERSHIPS AND DUES$13,687$10,445$3,242$0

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$40,575TotalAmt
Program Services$27,828ProgramServicesAmt
Management And General$11,563ManagementAndGeneralAmt
Fundraising$1,184FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$1,714,898TotalAmt
Program Services$1,435,206ProgramServicesAmt
Management And General$223,320ManagementAndGeneralAmt
Fundraising$56,372FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$24,249BOYAmt
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,975,333BOYAmt
EOY$1,990,906EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$127,915LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$115,647LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$15,258BOYAmt
EOY$12,268EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$2,014,840BOYAmt
EOY$2,003,174EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$1,583,840BOYAmt
EOY$1,568,760EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$431,000BOYAmt
EOY$434,414EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$2,014,840BOYAmt
EOY$2,003,174EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$2,014,840BOYAmt
EOY$2,003,174EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$11,666ReconcilationRevenueExpnssAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting OtherYes (X)MethodOfAccountingOtherInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Supporting Organization509a3Yes (X)SupportingOrganization509a3Ind
Supporting Org Type1Yes (X)SupportingOrgType1Ind
IRS Written DeterminationYes (X)IRSWrittenDeterminationInd
Supported Organizations1SupportedOrganizationsCnt

Supported Org Information SupportedOrgInformationGrp

Supported Organization Name SupportedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1GREATER KC COMM FNDTNBusinessNameLine1Txt
FieldValueIRS element (for citing)
EIN431152398EIN
Organization Type8OrganizationTypeCd
Governing Document ListedYes (1)GoverningDocumentListedInd
Support$0SupportAmt
Other Support$0OtherSupportAmt
FieldValueIRS element (for citing)
Supported Organizations Total1SupportedOrganizationsTotalCnt
Support Sum$0SupportSumAmt
Other Support Sum$0OtherSupportSumAmt

Form990 Sch A Supporting Org Form990SchASupportingOrgGrp

FieldValueIRS element (for citing)
Listed By Name Governing DocYes (1)ListedByNameGoverningDocInd
Suprt Org No IRS Determination0SuprtOrgNoIRSDeterminationInd
Supported Org Section C4560SupportedOrgSectionC456Ind
Supported Org Not Organized US0SupportedOrgNotOrganizedUSInd
Organization Change Suprt Org0OrganizationChangeSuprtOrgInd
Support Non Supported Org0SupportNonSupportedOrgInd
Payment Substantial Contribtr0PaymentSubstantialContribtrInd
Loan Disqualified Person0LoanDisqualifiedPersonInd
Controlled Disqualified Prsn0ControlledDisqualifiedPrsnInd
Disqualified Prsn Controll Int0DisqualifiedPrsnControllIntInd
Disqualified Prsn Ownr Int0DisqualifiedPrsnOwnrIntInd
Excess Business Holdings Rules0ExcessBusinessHoldingsRulesInd
Contribution Controller0ContributionControllerInd
Contribution Family0ContributionFamilyInd
Contribution35 Controlled0Contribution35ControlledInd

Form990 Sch A Type1 Suprt Org Form990SchAType1SuprtOrgGrp

FieldValueIRS element (for citing)
Power Appoint Majority Dir TrstYes (1)PowerAppointMajorityDirTrstInd
Operate Benefit Non Suprt Org0OperateBenefitNonSuprtOrgInd

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

FieldValueIRS element (for citing)
Filing Organizations Total$2,211FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$2,211FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,435,206FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

FieldValueIRS element (for citing)
Filing Organizations Total$1,437,417FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Filing Organizations Total$218,742FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Filing Organizations Total$54,686FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

FieldValueIRS element (for citing)
Filing Organizations Total$0FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

FieldValueIRS element (for citing)
Current Year Minus3$181,272CurrentYearMinus3Amt
Current Year Minus2$231,410CurrentYearMinus2Amt
Current Year Minus1$178,496CurrentYearMinus1Amt
Current Year$218,742CurrentYearAmt
Total$809,920TotalAmt
FieldValueIRS element (for citing)
Lobbying Ceiling$1,214,880LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

FieldValueIRS element (for citing)
Current Year Minus3$1,716CurrentYearMinus3Amt
Current Year Minus2$1,707CurrentYearMinus2Amt
Current Year Minus1$2,594CurrentYearMinus1Amt
Current Year$2,211CurrentYearAmt
Total$8,228TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

FieldValueIRS element (for citing)
Current Year Minus3$45,318CurrentYearMinus3Amt
Current Year Minus2$57,853CurrentYearMinus2Amt
Current Year Minus1$44,624CurrentYearMinus1Amt
Current Year$54,686CurrentYearAmt
Total$202,481TotalAmt
FieldValueIRS element (for citing)
Grassroots Ceiling$303,722GrassrootsCeilingAmt

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$52,126OtherCostOrOtherBasisAmt
Depreciation$40,751DepreciationAmt
Book Value$11,375BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$75,789OtherCostOrOtherBasisAmt
Depreciation$74,896DepreciationAmt
Book Value$893BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$12,268TotalBookValueLandBuildingsAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$1,703,232TotalRevEtcAuditedFinclStmtAmt
Revenue Not Reported$0RevenueNotReportedAmt
Revenue Subtotal$1,703,232RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$1,703,232TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$1,714,898TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$1,714,898ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$1,714,898TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART X, LINE 2:FormAndLineReferenceDesc
ExplanationKANSAS CITY AREA LIFE SCIENCES INSTITUTE, INC. HAS BEEN GRANTED AN EXEMPTION FROM INCOME TAXES BY THE INTERNAL REVENUE SERVICE UNDER THE PROVISIONS OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. THERE WAS NO UNRELATED BUSINESS INCOME DURING 2017 OR 2016. THE INSTITUTE HAS EVALUATED THE STANDARDS REQUIRING DISCLOSURE OF UNCERTAIN TAX POSITIONS UNDER FASB ASC 740, INCOME TAXES, AND DETERMINED THAT THERE ARE NO MATERIAL MATTERS WHICH REQUIRE DISCLOSURE.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (6 entries)

Address Line1USAddress/AddressLine1TxtAddress Line2USAddress/AddressLine2TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
UNIVERSITY OF MISSOURI
115 BUSINESS LOOP 70W MIZZOU NH RM501COLUBMIAMO65211436003859170(B)(1)(A)(II)$149,891KCALSI 17-4 COLLABORATE2CURE AWARD GUAUNFU LI; KCALSI 17-5 PATTON TRUST GRANT MONIQUE LORSON; KCALSI 17-11 NEXUS GRANT NATHAN SKELLEY
CHILDREN'S MERCY HOSPITAL
2401 GILLHAM ROADKANSAS CITYMO64108440605373501(C)(3)$196,560KCALSI 17-2 BLUE KC DR. COLVIN; KCALSI 17-3 BLUE KC DR. GOLDMAN; KCALSI 17-7 PATTON TRUST RESEARCH GRANT: SARAH SODEN; KCALSI 17-6 PATTON TRUST RESEARCH GRANT: TARAK SRIVASTAVA
KU MEDICAL CENTER RESEARCH INSTITUTE INC
3901 RAINBOW BLVDKANSAS CITYKS66160481108830501(C)(3)$50,000KCALSI 17-1 BLUE KC OUTCOMES STEVEN SIMPSON
UNIVERSITY OF KANSAS CENTER FOR RESEARCH
2385 IRVING HILL ROADLAWRENCEKS66045480680117501(C)(3)$50,000KCALSI 17-9 NEXUS GRANT WENDY PICKING
KANSAS STATE UNIVERSITY
102 ANDERSON HALLMANHATTANKS66506480771751170(B)(1)(A)(II)$99,964KCALSI 17-12 NEXUS GRANT RICHARD TODD; KCALSI 17-13 NEXUS GRANT MAJID JABERI-DOURAKI, PHD
KANSAS CITY UNIVERSITY
1750 INDEPENDENCE AVEKASNAS CITYMO64106440545280501(C)(3)$48,888KCALSI 17-8 COLLABORATE2CURE AWARD BAKI AGBAS
FieldValueIRS element (for citing)
Total501c3 Org4Total501c3OrgCnt
Total Other Org2TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationGRANTS ARE FOR A ONE YEAR DURATION. GRANT RECIPIENTS AGREE TO PROVIDE A PROGRESS REPORT AT SIX MONTHS AND A SUMMARY TECHNICAL PROGRESS REPORT WITHIN 30 DAYS OF THE END OF THE PERFORMANCE TO INCLUDE: 1. A BRIEF SUMMARY OF TECHNICAL PROGRESS RELATIVE TO THE GOALS AND OBJECTIVES PROPOSED IN THE PROPOSAL. 2. A BRIEF STATEMENT CONCERNING THE EFFECTIVENESS AND BENEFITS REALIZED FROM THE COLLABORATIONS INVOLVED. GRANT RECIPIENTS AGREE TO PROVIDE (UPON REQUEST) A COPY OF ALL PROPOSALS SUBMITTED TO EXTERNAL FUNDING AGENCIES AS A RESULT OF THE SUPPORT PROVIDED AND SUBSEQUENTLY NOTIFY KCALSI OF ACCEPTANCE OR REJECTION THEREOF. IF THE GRANT RECIPIENT RECEIVES ALTERNATIVE FUNDS FOR SUPPORT OF THIS SPECIFIC PROJECT, KCALSI REQUESTS THAT THE RECIPIENT RETURN ANY UNEXPENDED FUNDS TO THE INSTITUTE SO THAT THEY CAN BE USED TO SUPPORT OTHER INVESTIGATORS.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (2 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
WAYNE O CARTER
PRESIDENT$256,994$0$0$0$0$0$27,000$0$9,421$0$293,415$0$0$0
KEITH A GARY
VICE PRESIDENT$160,160$0$0$0$0$0$16,785$0$9,150$0$186,095$0$0$0

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (8 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART III, LINE 4A2017 ACCOMPLISHMENTS: 1. REGIONAL LIFE SCIENCES STRATEGIC ASSESSMENT-"PATH TO 2025" THE KANSAS CITY AREA LIFE SCIENCES INSTITUTE (KCALSI) ENGAGED DELOITTE TO EXECUTE A STRATEGIC ASSESSMENT OF THE REGIONAL LIFE SCIENCES IN 2015. THE PROCESS UTILIZED THE "COLLECTIVE IMPACT" MODEL FROM STANFORD UNIVERSITY AND WAS LED BY AN EXPERIENCED STEERING COMMITTEE COMPRISED OF COMMUNITY AND BUSINESS LEADERS IN THE LIFE SCIENCES. THE COMMITTEE LOOKED AT BOTH DRIVERS OF CLUSTER ENHANCEMENT AND REGIONAL SCIENTIFIC STRENGTHS. THE REGIONAL VISION DEVELOPED THROUGH THE ASSESSMENT PROCESS STATES, "THE KANSAS CITY REGION IS A GLOBAL LEADER AT THE NEXUS OF HUMAN AND ANIMAL HEALTH BENEFITING ALL OUR CITIZENS AND THE ECONOMY." THESE NEXUS OPPORTUNITIES WILL BE DIFFERENT FOR EACH STRATEGIC AREA AND WILL LIKELY RANGE FROM USING NATURALLY OCCURRING CANCER IN DOGS FOR ACCELERATING HUMAN DISCOVERIES TO ADVANCING OUR STRENGTH IN HEALTH IT AND OUTCOMES RESEARCH. FOUR AREAS OF SCIENTIFIC STRENGTH WERE IDENTIFIED: ANIMAL HEALTH, CANCER RESEARCH AND CARE, NEUROSCIENCE, AND HEALTH IT AND OUTCOMES RESEARCH. ADDITIONALLY, FOUR DRIVERS OF CLUSTER ENHANCEMENT WERE IDENTIFIED: COLLABORATION, WORKFORCE DEVELOPMENT, CAPITAL FORMATION, AND MESSAGING AND MARKETING. TASK FORCES WERE CREATED FOR EACH CLUSTER DRIVER AND WORK GROUPS FOR EACH SCIENTIFIC AREA. THE WORK OF THESE GROUPS WILL BE CRITICAL FOR THE SUCCESS OF OUR ENTIRE ECOSYSTEM AND ENABLE US TO BE MORE GLOBALLY COMPETITIVE. FY2017 PROGRESS IMPLEMENTATION OF THE "PATH TO 2025" IS DESCRIBED BELOW. WHILE ALL WORKING GROUPS WERE RECOGNIZING POWERFUL SYNERGIES WITHIN THE STRATEGY AND EXPLORING OPPORTUNITIES, TWO SIGNIFICANT THEMES FRAMED MOST OF OUR ACTIVITIES THROUGHOUT 2017: -THE NEXUS OF HUMAN AND ANIMAL HEALTH -OUTCOMES RESEARCH AND HEALTH IT THE NEXUS OF HUMAN AND ANIMAL HEALTH: THE NEXUS OF HUMAN AND ANIMAL HEALTH IS AN OPPORTUNITY TO ADVANCE HUMAN AND ANIMAL HEALTH BY BRINGING THESE SECTORS TOGETHER AND LOOKING FOR OVERLAP AND SYNERGY. EXAMPLES OF HUMAN/ANIMAL HEALTH NEXUS OPPORTUNITIES PURSUED IN 2017 INCLUDE: -REGIONAL COMPARATIVE ONCOLOGY PROGRAM. ONLY 11% OF CANCER DRUGS EFFECTIVE IN MICE HAVE BEEN APPROVED FOR TREATMENT IN PEOPLE. MEANWHILE, VETERINARIANS HAVE USED HUMAN CHEMOTHERAPEUTICS AS OFF-LABEL CANCER TREATMENTS FOR DOGS AND CATS FOR DECADES NOTING SIMILAR EFFICACY AND SIDE EFFECTS AS IN HUMANS ACROSS A RANGE OF TUMOR TYPES. THE CANCER RESEARCH AND CARE WORKING GROUP, LED BY DR. ROY JENSEN, BEGAN PLANS TO ACCELERATE CANCER THERAPEUTICS FOR PEOPLE AND PETS. THE REGIONAL COMPARATIVE ONCOLOGY PROGRAM IS AIMED AT FACILITATING TRANSLATIONAL CANCER DRUG DEVELOPMENT ACROSS THE NEXUS OF HUMAN AND ANIMAL MEDICINE. ONE EFFORT BEING PLANNED IS A VETERINARY ONCOLOGIST WITH CONCURRENT APPOINTMENTS IN THE REGIONAL VETERINARY SCHOOLS AND HUMAN CANCER CENTERS WOULD FACILITATE CLINICAL RESEARCH IN CLIENT-OWNED DOGS AND CATS WITH CANCER AS A TOOL TO SPEED UP HUMAN "PROOF OF CONCEPT" DRUG RESEARCH. -AS A DIRECT OUTCOME OF THE COLLABORATE2CURE SERIES ON CANCER IMMUNOTHERAPY, A CLINICAL PARTNERSHIP WAS DEVELOPED BETWEEN CHILDREN'S MERCY AND ELIAS ANIMAL HEALTH/TVAX BIOMEDICAL TO IMPACT PEDIATRIC ONCOLOGY. BIOLOGY OF PEDIATRIC OSTEOSARCOMA (BONE CANCER) AND CANINE OSTEOSARCOMA ARE VERY SIMILAR AND GENE EXPRESSION IS VIRTUALLY IDENTICAL BETWEEN CHILDREN AND DOGS. THIS PEDIATRIC ONCOLOGY PROGRAM WILL ENHANCE THE VALUE OF THIS TRANSLATIONAL OPPORTUNITY. -THE ANIMAL HEALTH WORKING GROUP IDENTIFIED A GAP AND A TREMENDOUS OPPORTUNITY FOR THE REGION. LED BY DR. RALPH RICHARDSON, K-STATE OLATHE CEO, AND DARYL PINT, CEVA CEO, THE GROUP RECOGNIZED THAT ANIMAL HEALTH RESEARCHERS LACKED A COMPREHENSIVE INTEROPERABLE DATABASE. THEY BEGAN DEVELOPING A PLAN LINKING ANIMAL HEALTH AND HUMAN HEALTH DATA VIA THE CERNER FHIR PLATFORM. NAMED "1DATA", THIS TRANSLATIONAL DATABASE PROVIDES A PLATFORM FOR MINING SHARED DATA FROM MANY SOURCES INCLUDING PHARMACEUTICAL DEVELOPMENT FOR PEOPLE AND ANIMALS, CLINICAL RECORDS, PROTEIN INTERACTIONS, GENOMIC AND ENVIRONMENTAL DATA. THE PROJECT IS LED BY DR. JERRY WYCKOFF, UNIVERSITY OF MISSOURI-KANSAS CITY (UMKC) PROFESSOR, AND DR. JIM RIVIERA, K-STATE PROFESSOR EMERITUS. THE OPPORTUNITIES WITHIN THE DATABASE ARE LIMITLESS. AMONG THEM IS THE GOAL TO SYSTEMATICALLY CHANGE THE REGULATORY PROCESS BY USING BIOLOGICAL MODELING AND SIMULATIONS TO ACCELERATE DRUG APPROVALS; ACCELERATE DEVELOPMENT OF HUMAN AND ANIMAL THERAPEUTICS AND DIAGNOSTICS; AND TO TRAIN STUDENTS IN BIOINFORMATICS, MODELING AND ANALYTICAL METHODS. THE 1DATA PLATFORM CAN BE USED BY RESEARCHERS, INDUSTRY, HEALTH PROVIDERS, AND COMMUNITY ORGANIZATIONS TO IMPACT THE DRUGS AND TECHNOLOGY AVAILABLE TO HELP SAVE LIVES AND IMPROVE THE QUALITY OF LIFE FOR HUMANS AND ANIMALS. -KCALSI BEGAN DEVELOPING THE NEXUS PROOF OF CONCEPT (POC) FUND AIMED AT ACCELERATING PHARMACEUTICAL DEVELOPMENT FOR HUMANS BY USING ANIMALS WITH NATURALLY OCCURRING DISEASE. HISTORICALLY, HUMAN HEALTH RESEARCHERS AND VETERINARY RESEARCHERS HAVE WORKED IN SILOS. THE PHARMACEUTICAL JUSTIFICATION FOR THE SEPARATION WAS PRESUMED REGULATORY HURDLES. AS OUR DISEASE UNDERSTANDING ADVANCES, MORE PEOPLE ARE APPRECIATING THE OPPORTUNITY AT THE NEXUS RATHER THAN THE HURDLES. THE FUND WILL PROVIDE PROOF OF CONCEPT FUNDING TO ADVANCE NOVEL TECHNOLOGIES TO MARKET THROUGH STUDIES NECESSARY TO DE-RISK THEM AND ATTRACT INVESTORS. TECHNOLOGY CONCEPTS WILL BE SOURCED FROM ENTREPRENEURS, UNIVERSITIES AND FROM INDUSTRY WHERE CONCEPT VALIDATION IS NEEDED TO ATTRACT ANGEL INVESTORS, VENTURE CAPITAL, OR LICENSING BY AN INDUSTRY PARTNER. MOST FUND INVESTMENTS WILL LIKELY BE LESS THAN $100K DEPENDING ON THE TECHNOLOGY AND STAGE GATES PROPOSED TO ACHIEVE PROOF OF CONCEPT. THE LACK OF POC FUNDING WAS IDENTIFIED IN KCALSI'S PATH TO 2025 REPORT, CONFIRMING SIMILAR FINDINGS IN KCSOURCELINK'S WE CREATE CAPITAL ASSESSMENT OF REGIONAL CAPITAL AVAILABILITY. THE NEXUS POC FUND HELPS CLOSE A SIGNIFICANT GAP IN THE REGIONAL ENTREPRENEURIAL ECOSYSTEM. OUTCOMES RESEARCH AND HEALTH IT OUTCOMES RESEARCH AND HEALTH IT PRINCIPLES CAN BE APPLIED IN ALL ASPECTS OF HEALTH AND DISEASE MANAGEMENT. EXAMPLES OF ACTIVITIES PURSUED IN 2017 INCLUDE: -THE NEURODEVELOPMENT WORKING GROUP BEGAN CONSIDERING AN OUTCOMES/HEALTH IT RESEARCH APPROACH TO BETTER DEFINE AUTISM SPECTRAL DISORDERS (ASD) WITH MORE CONSISTENT DIAGNOSTICS TO STEER THE TREATMENT APPROACH THAT WORKS BEST IN CHILDREN WITH ASD. THIS IS A CLASSIC OUTCOMES RESEARCH PROBLEM WHERE VARIABLE DIAGNOSTICS AND TREATMENTS ARE CONFOUNDING OUTCOMES FOR CHILDREN WITH ASD. -THE OUTCOMES RESEARCH / HEALTH IT WORKING GROUP, LED BY DICK FLANIGAN, CERNER PRESIDENT, AND DR. JOHN SPERTUS, SAINT LUKE'S HEALTH SYSTEM, UMKC, DEVELOPED A VISION STATEMENT TO FRAME THEIR WORK STATING, "THE KANSAS CITY REGION IS DEVELOPING A VALUE-BASED COLLABORATIVE HEALTHCARE ECOSYSTEM TO ESTABLISH KANSAS CITY AS 'THE OUTCOMES RESEARCH REGION' IN THE NATION." OUTCOMES RESEARCH RECOGNIZES PATIENT VARIATION ACROSS A POPULATION AND IDENTIFIES INDIVIDUAL PATIENT RISKS. IT PROVIDES A PERSONALIZED MEDICINE APPROACH DELIVERING TO PHYSICIANS THE TOOLS AND DATA TO TREAT A PATIENT AS AN INDIVIDUAL, INSTEAD OF TREATING THEM AS A MEAN OF THE POPULATION. -TO CREATE THIS ECOSYSTEM, THE GROUP RECOGNIZED THE NEED TO ENGAGE A CRITICAL MASS OF REGIONAL HOSPITALS IN AN OUTCOMES PROJECT TO DEMONSTRATE THE OPPORTUNITY IN VALUE-BASED HEALTHCARE. KEY ELEMENTS WERE IDENTIFIED FOR DEVELOPING A SUCCESSFUL OUTCOMES PROJECT TO ASSESS POTENTIAL CANDIDATE PROJECTS. AFTER CONSIDERABLE DELIBERATIONS, THE WORKING GROUP SELECTED PERCUTANEOUS CORONARY INTERVENTION (PCI) USING THE E-PRISM TOOL DEVELOPED BY HEALTH OUTCOME SCIENCES. THE E-PRISM TOOL USES OVER 90 PARAMETERS FROM A PATIENT'S ELECTRONIC MEDICAL RECORD TO DETERMINE BLEEDING AND ACUTE KIDNEY INJURY (AKI) RISKS FOLLOWING THE PROCEDURE AND PROVIDES THIS INFORMATION TO THE INTERVENTIONAL CARDIOLOGIST TO CUSTOMIZE TREATMENT FOR EACH PATIENT. SIGNIFICANT SAVINGS TO THE HOSPITAL ARE REALIZED IN AVOIDING ADVERSE EVENTS - OVER $8,000 PER PATIENT FOR BLEEDING, OVER $10,000 FOR EACH AKI EVENT, AND OVER $100,000 PER PATIENT FOR KIDNEY DIALYSIS, NOT TO MENTION THE BENEFIT FOR THE PATIENT. AT BARNES JEWISH HOSPITAL IN ST LOUIS, BLEEDING RATES AND AKI RATES DECREASED FROM ABOUT 8-10% AT BASELINE TO 2% WITH THE E-PRISM TOOL. ADDITIONALLY, THE HOSPITAL SAVES OVER $3,500,000 ANNUALLY IN THIS SINGLE PROCEDURE.
FORM 990, PART III, LINE 4A(CONTINUED) 2. COLLABORATE2CURE KCALSI CREATED THE COLLABORATE2CURE PROGRAM WITH THE GOAL OF STIMULATING REGIONAL SCIENTIFIC COLLABORATION AND DEVELOPING INNOVATIVE WAYS TO SOLVE SCIENTIFIC CHALLENGES. THE PROGRAM PROVIDES A PLATFORM FOR COLLABORATION, ALLOWING SCIENTISTS IN THE KC REGION TO SHARE THEIR RESEARCH AND ULTIMATELY COMPETE FOR FUNDING. KCALSI IDENTIFIES A TOPIC WITH SIGNIFICANT INTEREST TO RESEARCHERS WHICH ALIGNS WELL WITH REGIONAL EXPERTISE, AND THEN COORDINATES A SERIES OF PRESENTATIONS FROM RESEARCHERS OVER THE COURSE OF SEVERAL MONTHS. THE 2017 COLLABORATE2CURE SERIES FOCUSED ON "MITOCHONDRIAL DYSFUNCTION." SCIENTISTS, CLINICIANS, STUDENTS, AND ENTREPRENEURS GATHERED OVER 14 WEEKS TO SHARE AND GAIN KNOWLEDGE SURROUNDING MITOCHONDRIAL DYSFUNCTION. MITOCHONDRIA ARE THE ENERGY POWERHOUSE OF THE CELL AND ARE RESPONSIBLE FOR CREATING MORE THAN 90% OF THE ENERGY NEEDED BY THE BODY TO SUSTAIN LIFE AND SUPPORT ORGAN FUNCTIONS. DISEASES LINKED TO FAILING MITOCHONDRIA INCLUDE ALZHEIMER'S DISEASE, ALS, OBESITY, HEART DISEASE, AND NEUROLOGICAL DISEASES. THE MITOCHONDRIAL DYSFUNCTION SERIES WAS CO-CHAIRED BY DRS. ABDULBAKI "BAKI "AGBAS FROM KANSAS CITY UNIVERSITY AND RUSSELL SWERDLOW FROM THE UNIVERSITY OF KANSAS MEDICAL CENTER. AFTER THE SERIES, A REQUEST FOR PROPOSALS WAS RELEASED TO SUPPORT COLLABORATIVE, RESEARCH PROJECTS SPAWNED FROM THE SERIES. THE WINNING PROJECT RECEIVED $50,000 FOR ONE YEAR TO COMPLETE THE RESEARCH PROJECT. 3. WORKFORCE DEVELOPMENT WORKFORCE DEVELOPMENT WAS IDENTIFIED IN KCALSL'S PATH TO 2025 REPORT AS A SIGNIFICANT THREAT TO AND CRITICAL WEAKNESS IN THE REGIONAL LIFE SCIENCE CLUSTER. KC RISING, A CIVIC INITIATIVE UNDERWAY ACROSS THE KANSAS CITY COMMUNITY, ESTABLISHED A HUMAN CAPITAL WORK GROUP TO ADDRESS WORKFORCE DEVELOPMENT ISSUES. RECOGNIZING THE OPPORTUNITY TO LEVERAGE A PARALLEL EFFORT, KCALSI INTEGRATED ITS EFFORTS AND EXPERTISE WITH KC RISING TO DEVELOP A REGIONAL PLAN OF ACTION. 2017 ACTIVITIES IN SUPPORT OF WORKFORCE DEVELOPMENT INCLUDED THE FOLLOWING: -THE TALENT TO INDUSTRY EXCHANGE (TIE) CONCEPT WAS INTRODUCED TO IMPROVE LABOR SUPPLY IN KEY INDUSTRY SECTORS AND GROW THE WORKFORCE NECESSARY TO ATTRACT AND RETAIN COMPANIES IN THE KANSAS CITY REGION. ENGAGEMENT WITH LOCAL LIFE SCIENCE COMPANY LEADERS AND EDUCATIONAL INSTITUTIONS LAUNCHED IN 2016. THE LIFE SCIENCES TIE LABOR ANALYSIS WAS PUBLISHED IN FEBRUARY 2017. ONE OF THE KEY CHARGES WAS TO ESTABLISH A REGIONAL ADVISORY COUNCIL (RAC). MUCH LIKE A PLATFORM TECHNOLOGY, THE RAC CAN ASSESS A VARIETY OF WORKFORCE ISSUES AND IDENTIFY EDUCATION SOLUTIONS MORE RAPIDLY AND EFFICIENTLY, TO MEET INDUSTRY NEEDS. -BIOINFORMATICS WILL BE THE FIRST FOCUS AREA FOR THE RAC, AS THIS INDUSTRY SECTOR STRUGGLES TO ACQUIRE ADEQUATELY SKILLED WORKERS. WITH GUIDANCE FROM INDUSTRY, NEW CURRICULA WILL BE THE DELIVERABLE. -CONTRACT RESEARCH ORGANIZATIONS WILL BE THE SECOND FOCUS AREA. GIVEN THE EVER-CHANGING NATURE OF THEIR WORKFLOW, THIS INDUSTRY SECTOR IS RIPE FOR USING STACKABLE CREDENTIALS TO MEET TRAINING NEEDS. THESE SHORT-TERM CREDENTIALS CAN BE "STACKED," LEADING TO TWO AND FOUR-YEAR DEGREES. -THE EMERGING ENTREPRENEUR PROOF OF CONCEPT FUND (E2POC) PROGRAM HARVESTS ORPHAN TECHNOLOGIES DEVELOPED BY HIGH SCHOOL AND COLLEGE STUDENTS COMPETING IN REGIONAL STEM COMPETITIONS. TO INCREASE ENTREPRENEURS IN THE REGION, THE E2POC PROGRAM WILL ENGAGE STUDENT INVENTORS BY PROVIDING ENTREPRENEURSHIP RESOURCES, ASSISTING WITH BUSINESS PLAN DEVELOPMENT, ASSESSING MARKETS, INTELLECTUAL PROPERTY, AND ACCESSING CAPITAL. APPROXIMATELY 3 - 5 SUCCESSFUL APPLICANTS ANNUALLY WILL RECEIVE $5,000 SCHOLARSHIPS AND THE E2POC WILL FUND THE PROOF OF CONCEPT WORK AND PATENT PROSECUTION. THE ENTREPRENEUR WILL BE PAIRED WITH BUSINESS MENTORS TO AUGMENT THEIR ENTREPRENEURIAL EDUCATION. ADDITIONAL SCHOLARSHIPS WILL BE GRANTED, UP TO $20,000, AS THE PRODUCT MOVES TOWARD COMMERCIALIZATION. THE E2POC HAS TWO IMPORTANT OUTCOMES: (1) TRAIN YOUNG ENTREPRENEURS, AND (2) ADVANCE INNOVATIVE TECHNOLOGIES TO MARKET BY DIRECTLY FUNDING THE TECHNICAL STUDIES NECESSARY TO DE-RISK THEM TO ATTRACT INVESTORS. 4. KCALSI'S RESEARCH DEVELOPMENT GRANT PROGRAMS THE KCALSI RESEARCH DEVELOPMENT GRANTS PROGRAM REPRESENTS ONE OF OUR OLDEST AND MOST POPULAR PROGRAMS. GRANTS ARE AWARDED TO GENERATE PRELIMINARY DATA THAT SUPPORT SUBMISSION OF MAJOR MULTIDISCIPLINARY RESEARCH PROPOSALS TO GOVERNMENT OR PRIVATE FUNDING AGENCIES. APPLICANTS RECEIVE WRITTEN PEER REVIEWS, REGARDLESS OF WHETHER THEIR PROJECT RECEIVED FUNDING, TO HELP THEM IMPROVE FUTURE GRANT APPLICATIONS. THIS IS A VALUED SERVICE APPRECIATED BY ALL TEN STAKEHOLDERS. FROM 2007 TO 2017, KCALSI HAS MANAGED 77 GRANTS TOTALING $3.7 MILLION. ON AVERAGE, FOR EVERY $1 INVESTED IN GRANTS, $9.10 HAS BEEN RETURNED TO THE REGION FROM FOLLOW-ON FEDERAL SOURCES. IMPORTANTLY, THIS NUMBER SHOULD BE VIEWED CONSERVATIVELY AS NO INFORMATION IS READILY AVAILABLE REGARDING GRANTS MADE TO REGIONAL SCIENTISTS BY PRIVATE FOUNDATIONS AND PATIENT ADVOCACY ORGANIZATIONS. THE 2017 KCALSI RESEARCH DEVELOPMENT GRANT PORTFOLIO INCLUDES: BLUE KC OUTCOMES RESEARCH GRANTS FOCUS ON IMPROVING THE HEALTHCARE QUALITY, REDUCING COSTS, IMPROVING EFFECTIVENESS OR EFFICIENCY OF THE HEALTHCARE PROCESS, AND/OR IMPROVING ACCESS TO HEALTHCARE. PARTNERING WITH BLUE CROSS AND BLUE SHIELD OF KANSAS CITY, KCALSI AWARDED THREE GRANTS OF UP TO $50,000 EACH IN MAY 2016. THE GRANTS WERE PRESENTED TO THREE RESEARCH SCIENTISTS, TWO AT CHILDREN'S MERCY AND ONE AT THE UNIVERSITY OF KANSAS MEDICAL CENTER. PAUL PATTON CHARITABLE TRUST GRANTS FOCUS ON GENETIC DISEASES MAINLY AFFECTING CHILDREN. THE FUNDS FOR THIS PROGRAM ARE PROVIDED BY THE PAUL PATTON TRUST, TED C. MCCARTER, WILLIAM EVANS JR. AND BANK OF AMERICA, N.A., TRUSTEE. KCALSI AWARDED GRANTS OF UP TO $50,000 TO THREE RESEARCHERS, TWO AT CHILDREN'S MERCY, AND ONE AT THE UNIVERSITY OF MISSOURI. NEXUS OF HUMAN AND ANIMAL HEALTH GRANTS FOCUS ON BIOMEDICAL RESEARCH PROJECTS, RANGING FROM USING NATURALLY OCCURRING DISEASES IN ANIMALS AS A MODEL FOR ASSESSING HUMAN DRUG EFFICACY TO REPURPOSING HUMAN DRUGS FOR USE IN ANIMAL DISEASES. FUNDED BY THE HALL FAMILY FOUNDATION, KCALSI AWARDED $50,000 GRANTS EACH TO FIVE RESEARCHERS, THREE AT KANSAS STATE UNIVERSITY, ONE AT THE UNIVERSITY OF MISSOURI, AND ONE AT THE UNIVERSITY OF KANSAS. COLLABORATE2CURE GRANTS ARE SPECIFICALLY USED TO SUPPORT NEW COLLABORATIONS AND INNOVATIVE APPROACHES TO SOLVING PROBLEMS SPAWNED FROM THE COLLABORATE2CURE PROGRAM SERIES. KCALSI AWARDED TWO $50,000 GRANTS EACH TO RESEARCHERS AT THE UNIVERSITY OF MISSOURI AND KANSAS CITY UNIVERSITY. 5. 2017 ANNUAL DINNER AND "SCIENCE TO ART" AUCTION CLOSE TO 500 COMMUNITY LEADERS, SCIENTIFIC LEADERS, AND COLLEGE AND HIGH SCHOOL STUDENTS ATTENDED THE SEPTEMBER 19, 2017 KCALSI ANNUAL DINNER. NINA TANDON, FOUNDER AND CEO OF EPIBONE, PROVIDED THE CAPTIVATING KEYNOTE PRESENTATION EMPHASIZING SEVERAL WAYS THE AUDIENCE COULD HELP ADVANCE OUR FUTURE. HER PRESENTATION PROVIDED EXAMPLES OF INNOVATIVE APPROACHES TO TISSUE ENGINEERING. "IT'S VERY EXCITING BECAUSE WHAT WE'RE DOING IS CONNECTING WITH WHAT THE BODY DOES NATURALLY," SHE SAID. DR. TANDON URGED THE AUDIENCE TO LEVERAGE THE UNIQUE STRENGTHS OF THIS REGION, E.G., THE ANIMAL HEALTH CORRIDOR, CONCENTRATION OF CONTRACT RESEARCH ORGANIZATIONS (CROS), ETC. SHE FURTHER ENCOURAGED THE REGION TO FOSTER A RICH LIFE SCIENCES ECOSYSTEM, AND TO IDENTIFY PATHWAYS BRIDGING THE VENTURE CAPITAL FUNDING GAP. SHE CLOSED HER PRESENTATION BY REMINDING US THAT SCIENTIFIC ETHICS ARE CRUCIAL TO ADVANCE OUR FUTURE. DR. WAYNE CARTER, KCALSI PRESIDENT AND CEO, PROVIDED A PERSPECTIVE ON THE NEXUS OF HUMAN AND ANIMAL MEDICINE BY HIGHLIGHTING REGIONAL COMPANIES THAT ARE ADVANCING OUR FUTURE WITH NEW THERAPIES FOR PEOPLE AND DOGS, AND EXECUTION ON THE PATH TO 2025 STRATEGY. DR. CARTER CONCLUDED WITH A CALL-TO-ACTION TO ADVANCE OUR FUTURE, ENCOURAGING THE AUDIENCE TO: (1) CONTINUE TO COLLABORATE (2) MENTOR HIGH SCHOOL AND EARLY COLLEGE STUDENTS, AND (3) INVEST IN REGIONAL FUNDING PROGRAMS AND STARTUP COMPANIES. THIS WAS THE FOURTH CONSECUTIVE YEAR FOR KCALSI'S SCIENCE TO ART SILENT AUCTION HELD DURING OUR ANNUAL DINNER. BIDDING WAS AVAILABLE TO THE PUBLIC THROUGH THE KCALSI WEBSITE DURING THE SIX-WEEK EXHIBITION OF THE ARTWORK AT KEMPER AT THE CROSSROADS. THE KEMPER MUSEUM OF CONTEMPORARY ART WAS AN INSTRUMENTAL PARTNER FOR THIS EXHIBIT. THIS YEAR'S AUCTION PROCEEDS OF OVER $10,000 WERE MADE AVAILABLE FOR STEAM EDUCATION, SPECIFICALLY BIOGENEIUS, PREP-KC, SCIENCE CITY AND THE GREATER KANSAS CITY SCIENCE & ENGINEERING FAIR, AND FREE EDUCATIONAL PROGRAMS AT THE KEMPER MUSEUM.
FORM 990, PART III, LINE 4A(CONTINUED) 6. ONE HEALTH INNOVATIONS SYMPOSIUM THE 2017 ONE HEALTH INNOVATIONS: PREVENTING THE NEXT PANDEMIC SYMPOSIUM WAS HELD AUGUST 27-28 AT THE KANSAS CITY CONVENTION CENTER. KCALSI COORDINATED THIS TWO-DAY EVENT ALONG WITH THE UNIVERSITY OF MISSOURI, KANSAS STATE UNIVERSITY AND INDUSTRY PARTNERS. THE SYMPOSIUM FEATURED OVER 20 NATIONAL AND REGIONAL EXPERTS ADDRESSING THIS TOPIC FROM TWO PERSPECTIVES: (1) HOW CAN SURVEILLANCE DATA, SOCIAL TRAFFICKING, AND BIG DATA BE USED TO IDENTIFY POTENTIAL OUTBREAKS EARLIER, TO FACILITATE RAPID RESPONSE, AND (2) WHAT ARE THE LATEST VACCINE PLATFORMS BEING APPLIED TO VIRAL AND EMERGING DISEASES INCLUDING A SEGMENT ON NOVEL TREATMENT APPROACHES. THE SYMPOSIUM FEATURED THREE KEYNOTE PRESENTERS, DR. GREG GRAY, DUKE UNIVERSITY, "ONE HEALTH: AN INCREASINGLY POPULAR APPROACH TO WICKED GLOBAL HEALTH PROBLEMS," DR. MARK CHALLBERG, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES WHO DISCUSSED, "ZIKA VACCINE DEVELOPMENT: STARTING FROM SCRATCH, AND DR. MARTY VANIER, WITH THE NATIONAL BIO AND AGRO-DEFENSE FACILITY WHO PRESENTED ON "NATIONAL BIO AND AGRO-DEFENSE FACILITY: A NEW PARADIGM. HIGHLIGHTS OF DAY 1 INCLUDED DR. TRACEY MCNAMARA WHO FIRST IDENTIFIED WEST NILE VIRUS IN THE UNITED STATES, AND DR. JORGE SOBERON WHO DISCUSSED DISEASE SPREAD USING ECOLOGY AND EVOLUTIONARY BIOLOGY. DAY 2 INCLUDED PRESENTATIONS BY DR. SCOTT MCVEY FEATURING FAST-TRACK APPROACHES FOR EMERGING DISEASES AND DR. SAMUEL THEVASAGAYAM FROM THE GATES FOUNDATION FOCUSED ON CHALLENGES OF SUB-SAHARAN AFRICA VACCINE MANUFACTURING. 7. ONE HEALTH DAY THE ONE HEALTH CONCEPT LEVERAGES MULTIPLE DISCIPLINES WORKING LOCALLY, NATIONALLY AND GLOBALLY LINKING HUMAN HEALTH, ANIMAL HEALTH, AND THE ENVIRONMENT. KCALSI PARTNERED WITH KANSAS STATE UNIVERSITY AND BIOKANSAS TO HOST "KANSAS CITY ONE HEALTH DAY." DR. CARTER PROVIDED AN OVERVIEW OF ONE HEALTH. HE NOTED THAT A FOCUSED RESEARCH APPROACH IS IMPORTANT, HOWEVER, BEING ABLE TO SEE THE BIG PICTURE RELATING TO INTERDISCIPLINARY DATA IS CRITICAL. PANELISTS INCLUDED, DR. BARBARA BICHELMEYER, INTERIM CHANCELLOR, UMKC, DR. TOM CURRAN, CHIEF SCIENTIFIC OFFICER, CHILDREN'S MERCY, KELLY RANALLO, FOUNDER, RAREKC, DENNIS RIDENOUR, PRESIDENT AND CEO OF BIOKANSAS, DR. LAURA TREML, VP OF DRUG DEVELOPMENT, ARATANA, AND DR. RAELENE WOUDA, ASSISTANT PROFESSOR, K-STATE COLLEGE OF VETERINARY MEDICINE. THEY EMPHASIZED THE NEED TO MOVE OUT OF DISCIPLINARY SILOS TO ADVANCE ONE HEALTH. TAKING THIS APPROACH POSITIONS HUMAN, ANIMAL, AND ENVIRONMENTAL RESEARCH AS CRUCIAL ELEMENTS CONTRIBUTING TO FINDING NEW CURES. 8. BIOINFORMATICS 1. IN 2017, KCALSI CREATED A TOOL FOR THE REGION TO ORGANIZE BIOINFORMATICS ASSETS SUPPORTING HUMAN AND ANIMAL HEALTH RESEARCH. THIS WEBSITE INCLUDES CAPABILITIES AND RESEARCH EXPERTISE TO FACILITATE COLLABORATIVE RESEARCH. WWW.KCBIOINFORMATICS.ORG 2. IN PARTNERSHIP WITH CHILDREN'S MERCY AND UMKC, KCALSI PRESENTED THE SECOND ANNUAL MIDWEST BIOINFORMATICS CONFERENCE ON APRIL 13 -14, 2017 FEATURING 30 SPEAKERS SHOWCASING PRACTICAL APPROACHES TO COLLECTING, ORGANIZING, AND PREPARING DATA FOR A BROAD RANGE OF ANALYSES APPLIED IN HUMAN AND ANIMAL HEALTH. THE CONFERENCE WAS HOSTED ON THE UMKC CAMPUS AND CONVENED NEARLY 200 BIOINFORMATICS-MINDED RESEARCHERS FROM ACADEMIA AND INDUSTRY TO DISCOVER CAPABILITIES, SHARE TACTICAL APPROACHES TO PROBLEM-SOLVING, EXPLORE SYNERGIES, AND LAUNCH POTENTIAL COLLABORATIONS. ADDITIONALLY, BIOINFORMATICS STUDENTS LEARNED ABOUT EMPLOYMENT OPPORTUNITIES WITHIN THE REGION AND PARTICIPATED IN MOCK INTERVIEWS. INTRODUCED THIS YEAR, A SUBSET OF 29 STUDENT POSTERS WAS CONSIDERED FOR PODIUM PRESENTATIONS, WITH FOUR STUDENTS SELECTED FOR THIS HONOR. 9. W.I.S.E KC KCALSI REALIZES THAT EMPOWERING WOMEN AND ADVOCACY FOR WOMEN IN SCIENCE AND ENTREPRENEURSHIP (W.I.S.E.) IS CRUCIAL FOR DEVELOPING THE NEXT GENERATION OF WOMEN IN STEM. KCALSI ORGANIZED THE W.I.S.E. KC" EVENT IN PARTNERSHIP WITH BIOKANSAS, MISSOURI CURES, AND THE MISSOURI BIOTECHNOLOGY ASSOCIATION. THE EVENT INCLUDED A PANEL WITH FOUR FEMALE ENTREPRENEURS: ELIZABETH LOBOA, DEAN OF THE COLLEGE OF ENGINEERING AT THE UNIVERSITY OF MISSOURI, REBECCA MACKINNON, PRINCIPAL AND FOUNDER OF 5TH DIMENSION STRATEGIES, TAMMIE WAHAUS, CEO OF ELIAS ANIMAL HEALTH, AND NANCY ZURBUCHEN, SMALL BUSINESS ADVOCATE, REGION 7, SMALL BUSINESS ADMINISTRATION. THE PANELISTS SHARED CAREER EXPERIENCES WITH OVER 200 ATTENDEES AT THE KAUFFMAN FOUNDATION. DEAN LOBOA FOCUSED ON LOW ENROLLMENT, AND GRADUATION STATISTICS ABOUT FEMALE ENGINEERING STUDENTS LOCALLY AND NATIONALLY. THE PANELISTS ENCOURAGED TAKING ACTION TO INCREASE WOMEN IN STEM CAREERS. LOBOA IS LEADING BY EXAMPLE AND DEMANDING CHANGE FROM HER PEERS. THE CHALLENGE IS TO BE MORE THAN A MENTOR, BE A SPONSOR BY HELPING TO IDENTIFY, PROMOTE, AND ADVOCATE FOR WOMEN WITHIN YOUR ORGANIZATIONS. INCREASING WOMEN IN SCIENCE INCREASES THE SUCCESS OF STEM COMPANIES.
FORM 990, PART VI, SECTION A, LINE 2ANNE D. ST. PETER AND STEVEN ST. PETER,MD HAVE A FAMILY RELATIONSHIP.
FORM 990, PART VI, SECTION B, LINE 11BTHE ORGANIZATION HAS A POLICY FOR THE ORGANIZATION'S AUDIT COMMITTEE TO REVIEW THE 990 BEFORE IT IS FILED.
FORM 990, PART VI, SECTION B, LINE 12CALL STAFF AND DIRECTORS MUST SUBMIT ANY CONFLICTS OF INTEREST ON AN ANNUAL BASIS. IF A CONFLICT ARISES WITHIN THE BOARD, THE DISCLOSING INDIVIDUAL SHALL NEITHER VOTE NOR ENDEAVOR TO INFLUENCE THE DECISION.
FORM 990, PART VI, SECTION B, LINE 15ACOMPENSATION OF THE ORGANIZATION'S PRESIDENT IS AGREED UPON BY THE BOARD OF DIRECTORS AND FINALIZED VIA A WRITTEN EMPLOYMENT CONTRACT. THIS APPROVAL IS DOCUMENTED IN THE MINUTES OF THE BOARD. IN 2013 THE ORGANIZATION CREATED A COMPENSATION COMMITTEE AND CONDUCTED A COMPENSATION STUDY TO FURTHER REFINE THE COMPENSATION PROCESS.
FORM 990, PART VI, SECTION C, LINE 19THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE ONLY AVAILABLE UPON REQUEST.

Schedule R IRS990ScheduleR

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdDirect Controlling NADirectControllingNACdEntity TypeEntityTypeTxtOwnershipOwnershipPctControlled OrganizationControlledOrganizationInd
KC BIO HOLDINGS INC
30 W PERSHING ROAD STE 210KANSAS CITYMO64108412115941LIFE SCIENCESMON/AC1.00000Yes (1)
(no name)
Yes (1)
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.